SCHEMBL2993002

SCHEMBL2993002

CCOC(=O)N1CCc2cc(I)sc2CC1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 4/20 0.41
CYP3A4 P08684 3/20 0.41
CYP1A2 P05177 2/20 0.41
ALDH1A1 P00352 4/20 0.41
MAPT P10636 5/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
GAA P10253 3/20 0.41
POLB P06746 2/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
TDP1 Q9NUW8 2/20 0.40
ABL1 P00519 1/20 0.40
RIN1 Q13671 1/20 0.40
KDM4E B2RXH2 3/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
TSHR P16473 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13560073 0.86 ALDH1A1 (0.43) GRM5CYP3A4CYP1A2ALDH1A1MAPT
SCHEMBL984992 0.83 POLB (0.47) GRM5CYP3A4CYP1A2ALDH1A1MAPT
SCHEMBL11176901 0.82 KDM4E (0.48) GRM5CYP3A4CYP1A2ALDH1A1MAPT
SCHEMBL11180673 0.82 ALDH1A1 (0.51) GRM5CYP3A4CYP1A2ALDH1A1MAPT
SCHEMBL16038585 0.82 GRM5 (0.43) GRM5CYP3A4CYP1A2ALDH1A1MAPT
SCHEMBL1181655 0.82 HDAC6 (0.47) GRM5CYP3A4CYP1A2ALDH1A1MAPT
SCHEMBL3007853 0.81 KCNQ2 (0.46) GRM5CYP3A4CYP1A2ALDH1A1MAPT
SCHEMBL13266222 0.81 HDAC6 (0.43) GRM5CYP3A4CYP1A2ALDH1A1MAPT
SCHEMBL15894787 0.81 SLC5A1 (0.41) GRM5CYP3A4CYP1A2ALDH1A1MAPT
SCHEMBL11319187 0.80 SMN1; SMN2 (0.41) GRM5CYP3A4CYP1A2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1778243-B1 SUBSTITUTED AZEPINE DERIVATIVES AS SEROTONIN RECEPTOR MODULATORS ATHERSYS INC (US) 2012-10-31 EP disclosed
US-20100190772-A1 Substituted Azepine Derivatives As Serotonin Receptor Modulators BENNANI YOUSSEF L 2010-07-29 US disclosed
US-7718647-B2 Substituted azepine derivatives as serotonin receptor modulators ATHERSYS, INC. (US) 2010-05-18 US disclosed
US-20060003990-A1 Substituted azepine derivatives as serotonin receptor modulators ATHERSYS, INC. 2006-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060003990-A1 Substituted azepine derivatives as serotonin receptor modulators HTR5A, HTR4, HTR7 GRM5 58/4885CYP3A4 465/4885CYP1A2 546/4885
US-20100190772-A1 Substituted Azepine Derivatives As Serotonin Receptor Modulators HTR5A, HTR4, HTR2C GRM5 52/4885CYP3A4 336/4885CYP1A2 390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.